BOLT
Bolt Biotherapeutics·NASDAQ
--
--(--)
--
--(--)
BOLT fundamentals
Bolt Biotherapeutics (BOLT) released its earnings on Aug 14, 2025: revenue was 1.80M (YoY +41.18%), beat estimates; EPS was -4.46 (YoY +60.18%), beat estimates.
Revenue / YoY
1.80M
+41.18%
EPS / YoY
-4.46
+60.18%
Report date
Aug 14, 2025
Earnings Call
7:00 AM on Aug 14, 2025
Meeting link.EPS
Actual | -291.4 | -21.8 | -12.8 | -12.6 | -14.6 | -12.8 | -12.2 | -11.6 | -10.6 | -9 | -9.6 | -8.6 | -9.4 | -5.6 | -11.2 | -8 | -8.4 | -5.8 | -4.46 |
Forecast | -12.8667 | -13.65 | -11.7 | -15 | -16.16 | -14.05 | -13.15 | -11.0667 | -11.7333 | -10 | -9.5333 | -10 | -9.4 | -10.2 | -8.76 | -6.8 | -7.6 | -7.1 | -6.3 |
Surprise | -2164.76% | -59.71% | -9.40% | +16.00% | +9.65% | +8.90% | +7.22% | -4.82% | +9.66% | +10.00% | -0.70% | +14.00% | 0.00% | +45.10% | -27.85% | -17.65% | -10.53% | +18.31% | +29.21% |
Revenue
Actual | 0 | 0 | 0 | 752.00K | 508.00K | 813.00K | 1.39M | 2.11M | 1.41M | 1.83M | 1.43M | 2.53M | 2.09M | 5.27M | 1.27M | 1.14M | 10.00K | 1.22M | 1.80M |
Forecast | 33.33K | 0 | 3.33M | 375.00K | 375.00K | 500.00K | 500.00K | 990.00K | 1.24M | 1.54M | 1.91M | 1.73M | 1.71M | 2.08M | 1.01M | 1.25M | 775.67K | 757.25K | 819.75K |
Surprise | -100.00% | 0.00% | -100.00% | +100.53% | +35.47% | +62.60% | +178.60% | +113.33% | +14.25% | +18.57% | -25.00% | +46.47% | +21.96% | +154.17% | +26.82% | -8.76% | -98.71% | +61.37% | +119.58% |
Earnings Call
You can ask Aime
What is Bolt Biotherapeutics's latest dividend and current dividend yield?What does Bolt Biotherapeutics do and what are its main business segments?What guidance did Bolt Biotherapeutics's management provide for the next earnings period?Did Bolt Biotherapeutics beat or miss consensus estimates last quarter?What is Bolt Biotherapeutics's gross profit margin?What factors drove the changes in Bolt Biotherapeutics's revenue and profit?What is the market's earnings forecast for Bolt Biotherapeutics next quarter?What were the key takeaways from Bolt Biotherapeutics’s earnings call?
